title: [Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008535:Megestrol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019290:Megestrol Acetate; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011897:Random Allocation
chemical_list: D000970:Antineoplastic Agents; D017258:Medroxyprogesterone Acetate; D008535:Megestrol; D008525:Medroxyprogesterone; D019290:Megestrol Acetate
vernacular_title: Megestrolazetat versus medroxyprogesteronazetat in der Behandlung metastasierender Mammakarzinome. Zwischenbericht einer multizentrischen Phase-III-Studie.